NCT05172245 2026-03-18
Testing the Addition of Ipatasertib to Usual Chemotherapy and Radiation for Head and Neck Cancer
National Cancer Institute (NCI)
Phase 1 Recruiting
Clinical Trials
7 trialsNCT04900623 2025-07-30
Risk-adapted Therapy in HPV+ Oropharyngeal Cancer Using Circulating Tumor (ct)HPV DNA Profile - The ReACT Study
Dana-Farber Cancer Institute
Phase 2 Recruiting
NCT06702033 2025-04-15
MINT-2
Washington University School of Medicine
Phase 2 Recruiting
NCT05784012 2025-03-13
RADIAN
Grupo Español de Tratamiento de Tumores de Cabeza y Cuello
Phase 1/2 Recruiting
NCT06554158 2025-03-06
De-escalation of Adjuvant Radiation for Low-Risk HPV Oropharyngeal Cancers
Georgetown University
Phase NA Recruiting
NCT05800574 2024-12-24
Lymphoscintigraphy Directed Elective Neck Radiation for p16+ Favorable Risk Oropharynx Cancer
Fox Chase Cancer Center
Phase 2 Recruiting
NCT04019548 2023-05-10
SwallPEG
Jules Bordet Institute
Phase 3 Recruiting